about
Detection of alcohol abuse in neurological patients: variables of clinical relevance to the accuracy of the %CDT-TIA and CDTect methods.Symptoms of epilepsy and organic brain dysfunctions in patients with acute, brief depression combined with other fluctuating psychiatric symptoms: a controlled study from an acute psychiatric departmentEFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy.Cerebrospinal Fluid Aβ43 Is Reduced in Early-Onset Compared to Late-Onset Alzheimer's Disease, But Has Similar Diagnostic Accuracy to Aβ42.Late onset myasthenia gravis is associated with HLA DRB1*15:01 in the Norwegian population.EFNS guideline on the diagnosis and management of alcohol-related seizures: report of an EFNS task force.Validity of carbohydrate deficient transferrin and other markers as diagnostic aids in the detection of alcohol related seizures.Alpha-synuclein measured in cerebrospinal fluid from patients with Alzheimer's disease, mild cognitive impairment, or healthy controls: a two year follow-up study.The validity of questionnaire-based diagnoses: the third Nord-Trøndelag Health Study 2006-2008.A face-to-face interview of participants in HUNT 3: the impact of the screening question on headache prevalence.Cerebrospinal Fluid Levels of Amyloid Beta 1-43 in Patients with Amnestic Mild Cognitive Impairment or Early Alzheimer's Disease: A 2-Year Follow-Up Study.Quantitative EEG findings in patients with acute, brief depression combined with other fluctuating psychiatric symptoms: a controlled study from an acute psychiatric department.Cerebrospinal Fluid Levels of Amyloid Beta 1-43 Mirror 1-42 in Relation to Imaging Biomarkers of Alzheimer's Disease.A multinational study distinguishing Alzheimer's and healthy patients using cerebrospinal fluid tau/Aβ42 cutoff with concordance to amyloid positron emission tomography imaging.Treatment non-adherence in pseudo-refractory epilepsy.Alcohol withdrawal syndrome: mechanisms, manifestations, and management.The impact of sleep loss on the facilitation of seizures: A prospective case-crossover study.Detecting At-Risk Alzheimer's Disease Cases.Quantitative EEG in patients with alcohol-related seizures.The EEG response to photic stimulation is not increased in alcohol-related seizures.Clinical utility of EEG in alcohol-related seizures.Screening for Alzheimer's Disease: Cognitive Impairment in Self-Referred and Memory Clinic-Referred Patients.Treadmill Training or Progressive Strength Training to Improve Walking in People with Multiple Sclerosis? A Randomized Parallel Group Trial.Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer's disease.A structured, nurse-led intervention program improves quality of life in patients with epilepsy: a randomized, controlled trial.Treatment policies for alcohol-related seizures: a survey of European neurologistsCerebrospinal fluid neurogranin/β-site APP-cleaving enzyme 1 predicts cognitive decline in preclinical Alzheimer's diseaseThe relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer's diseaseThe Norwegian Cognitive impairment after stroke study (Nor-COAST): study protocol of a multicentre, prospective cohort studyGenetic meta-analysis identifies 9 novel loci and functional pathways for Alzheimers disease riskMeta-analysis of Alzheimer’s disease on 9,751 samples from Norway and IGAP study identifies four risk lociStroke risk after transient ischemic attack in a Norwegian prospective cohortGenome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease riskGBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association studyGenome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease riskIn Brief Neuropsychological Assessment, Amnestic Mild Cognitive Impairment (MCI) Is associated with Cerebrospinal Fluid Biomarkers for Cognitive Decline in Contrast to the Prevailing NIA-AA MCI CriterionThe diversity of seizures related to alcohol use. A study of consecutive patients[Acute headache--diagnostic considerations]An easily performed group education programme for patients with uncontrolled epilepsy--a pilot studyWeekday distribution of alcohol consumption in Norway: influence on the occurrence of epileptic seizures and stroke?
P50
Q31993722-ECC66D15-D506-4DA4-AF16-67135C248F91Q33507733-BD1BE1C5-44E3-4D3F-8D59-560434BB79D3Q33636075-5FB5925D-8DBD-425F-BBA0-DAB97FDF3710Q33843517-8130559A-892F-48D2-A371-6D61EB91DB45Q34270872-95BD897E-9682-4D5B-9B1E-26E73E6868CBQ34438266-D393105A-80B6-4DC1-9375-CAD657BDB5C6Q35455437-FCE4C12E-BFF0-466E-B9AE-8E8379B87A05Q36139579-3252BFBA-6A7B-4695-908E-8A8BBFC6BBE2Q36260849-80825CB5-C21A-49B3-B637-7C32AD728E1BQ36260916-87C106DA-A9BA-4A92-B6BA-B87D1A703BFAQ36634198-FA909DF2-C152-432C-AE98-BA9555982AE5Q36999612-A3D77D59-D216-45D9-82AE-B21BFE262B5AQ37627051-8A017D47-FEA4-487E-BE1E-78D474254448Q37710439-C97F327D-3B09-4EC6-93A2-82E91F72D821Q38742187-03BBA8BE-889D-4E0B-AE9A-A85F9E3C4D72Q38944364-25031754-9F28-491F-AF6D-56FEC5B68B86Q39354095-B55FDEBE-AE84-4380-8D4E-ECEAACCA8FFDQ41863951-50B0BE6F-8875-4F12-91CA-636E53725726Q42971796-E323FCF7-F4DA-4E13-B584-2E8B7F47D152Q43069009-DE640637-017B-46D9-A614-B7E3A3129198Q43923071-FDA99874-A89B-4378-A70B-AD8900BEE986Q47134237-B76ADDAA-B206-4936-A4E3-45F2935CA3B6Q48024953-8AFB169B-09C7-4B1B-8F25-311EBB0BE040Q49599316-AE6262DB-7407-4113-BE41-8817CF8342DDQ53286115-6ED552B4-A8DF-4EE0-8155-3D8FCC973041Q59683430-6599404B-4BB7-4C4A-9C8F-6E4982554D10Q59792207-F262ED4B-42D5-4664-B176-F98AD685EC5BQ59808210-6C74D372-2743-4BB5-9A5C-13740AFFE6EEQ59808473-2071BB29-8364-423C-B613-CE95CF788760Q59843529-8F52C887-6EDA-4C14-89AB-E31706E3274DQ60303872-55AB0FDE-FC63-4606-9037-EAA0D37887D2Q60921330-7F50D672-35AE-41ED-8C11-0A51B449B4B6Q62840254-5BEF1840-6730-4BB9-9262-7411553C8016Q64064642-87987B23-C61C-4A24-82F4-3860BF12524EQ64118849-7A3D90AD-5BB0-42E4-B729-0F1427232F18Q64236543-F4C1E0A3-72E6-4489-914C-925BFC582D0BQ73102534-5477E048-7BBD-4445-9889-0B537A67D46CQ73463280-DA1953E2-AB71-4211-BD72-27F2DA69760FQ73927343-FF1E5B03-E494-4DDD-A633-6E0B61E139B0Q74261436-F0697751-CC5A-4371-8DD9-A493C46298B2
P50
description
Noors onderzoeker
@nl
norsk forsker
@nb
researcher
@en
հետազոտող
@hy
name
G Bråthen
@ast
G Bråthen
@es
G Bråthen
@nl
G Bråthen
@sl
Geir Bråthen
@da
Geir Bråthen
@de
Geir Bråthen
@en
Geir Bråthen
@fr
Geir Bråthen
@nb
Geir Bråthen
@nn
type
label
G Bråthen
@ast
G Bråthen
@es
G Bråthen
@nl
G Bråthen
@sl
Geir Bråthen
@da
Geir Bråthen
@de
Geir Bråthen
@en
Geir Bråthen
@fr
Geir Bråthen
@nb
Geir Bråthen
@nn
prefLabel
G Bråthen
@ast
G Bråthen
@es
G Bråthen
@nl
G Bråthen
@sl
Geir Bråthen
@da
Geir Bråthen
@de
Geir Bråthen
@en
Geir Bråthen
@fr
Geir Bråthen
@nb
Geir Bråthen
@nn
P106
P21
P214
2713149068571265730004
P2287
P27
P31
P496
0000-0003-3224-7983
P7859
viaf-2713149068571265730004